These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6376353)

  • 1. Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1984 Jul; 45(1):139-42. PubMed ID: 6376353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of fatal experimental burn-wound sepsis due to Klebsiella pneumoniae KP1-O by immunization with homologous capsular polysaccharide.
    Cryz SJ; Fürer E; Germanier R
    J Infect Dis; 1984 Dec; 150(6):817-22. PubMed ID: 6389718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans.
    Cryz SJ; Fürer E; Germanier R
    J Infect Dis; 1985 Apr; 151(4):665-71. PubMed ID: 3882856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental Klebsiella pneumoniae burn wound sepsis: role of capsular polysaccharide.
    Cryz SJ; Fürer F; Germanier R
    Infect Immun; 1984 Jan; 43(1):440-1. PubMed ID: 6360907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization against fatal experimental Klebsiella pneumoniae pneumonia.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1986 Nov; 54(2):403-7. PubMed ID: 3533779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and vaccine potential of Klebsiella capsular polysaccharides.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1985 Oct; 50(1):225-30. PubMed ID: 4044036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
    McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR
    J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against fatal Klebsiella pneumoniae sepsis in the squirrel monkey Saimiri sciureus after immunization with a capsular polysaccharide vaccine.
    Postal JM; Gysin J; Crenn Y
    Ann Inst Pasteur Immunol; 1988; 139(4):401-7. PubMed ID: 3048318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical properties of oligosaccharide-protein conjugates with Klebsiella-K2-specificity. II. Protective capacity of the conjugates and anti-conjugate antibodies against infection with Klebsiella pneumoniae 01:K2 in mice.
    Geyer H; Schlecht S; Himmelspach K
    Med Microbiol Immunol; 1982; 171(3):135-43. PubMed ID: 6186899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked immunospecific antibody test for detecting antibody to Klebsiella.
    Rissing JP; Buxton TB; Moore WL; Ozawa T; Moore WL
    J Clin Microbiol; 1978 Dec; 8(6):704-7. PubMed ID: 370145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice.
    Kumari S; Harjai K; Chhibber S
    J Microbiol Biotechnol; 2010 May; 20(5):935-41. PubMed ID: 20519918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprotective activity of capsular polysaccharide in Klebsiella pneumoniae ribosomal preparations does not involve ribonucleic acid.
    Riottot MM; Fournier JM
    Infect Immun; 1981 Oct; 34(1):126-30. PubMed ID: 6170582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.
    Riottot M; Fournier JM; Pillot J
    Infect Immun; 1979 May; 24(2):476-82. PubMed ID: 378855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1984 Mar; 43(3):795-9. PubMed ID: 6698608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to Klebsiella pneumoniae and the importance of two bacterial antigens.
    Cooper JM; Rowley D
    Aust J Exp Biol Med Sci; 1982 Dec; 60(6):629-41. PubMed ID: 6820634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive immunization of mice against Klebsiella aerogenes.
    Roe EA; Jones RJ; Dyster RE
    Br J Exp Pathol; 1986 Feb; 67(1):25-32. PubMed ID: 3511939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A murine monoclonal antibody against Klebsiella capsular polysaccharide is opsonic in vitro and protects against experimental Klebsiella pneumoniae infection.
    Trautmann M; Cryz SJ; Sadoff JC; Cross AS
    Microb Pathog; 1988 Sep; 5(3):177-87. PubMed ID: 3063912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development.
    Cryz SJ; Mortimer PM; Mansfield V; Germanier R
    J Clin Microbiol; 1986 Apr; 23(4):687-90. PubMed ID: 3517058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection with bacteriophage KØ1 against fatal Klebsiella pneumoniae-induced burn wound infection in mice.
    Malik R; Chhibber S
    J Microbiol Immunol Infect; 2009 Apr; 42(2):134-40. PubMed ID: 19597645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.